Literature DB >> 9596473

Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.

L K Durham1, I M Longini, M E Halloran, J D Clemens, A Nizam, M Rao.   

Abstract

The authors present a nonparametric method for estimating vaccine efficacy as a smooth function of time from vaccine trials. Use of the method requires a minimum of assumptions. Estimation is based on the smoothed case hazard rate ratio comparing the vaccinated with the unvaccinated. The estimation procedure allows investigators to assess time-varying changes in vaccine-induced protection, such as those produced by waning and boosting. The authors use the method to reanalyze data from a vaccine trial of two cholera vaccines in rural Bangladesh. This analysis reveals the differential protection and waning effects for the vaccines as a function of biotype and age.

Keywords:  Asia; Bacterial And Fungal Diseases; Bangladesh; Cholera; Demographic Factors; Developing Countries; Diseases; Epidemiologic Methods; Infections; Methodological Studies; Population; Population Dynamics; Research Methodology; Southern Asia; Time Factors; Vaccines

Mesh:

Substances:

Year:  1998        PMID: 9596473     DOI: 10.1093/oxfordjournals.aje.a009385

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

1.  Randomization and baseline transmission in vaccine field trials.

Authors:  C J Struchiner; M E Halloran
Journal:  Epidemiol Infect       Date:  2007-02       Impact factor: 2.451

2.  Predicting Overall Vaccine Efficacy in a New Setting by Re-Calibrating Baseline Covariate and Intermediate Response Endpoint Effect Modifiers of Type-Specific Vaccine Efficacy.

Authors:  Peter B Gilbert; Ying Huang
Journal:  Epidemiol Methods       Date:  2016-01-23

3.  Vaccination strategies for epidemic cholera in Haiti with implications for the developing world.

Authors:  Dennis L Chao; M Elizabeth Halloran; Ira M Longini
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

4.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

5.  Critical immune and vaccination thresholds for determining multiple influenza epidemic waves.

Authors:  Laura Matrajt; Ira M Longini
Journal:  Epidemics       Date:  2011-12-07       Impact factor: 4.396

6.  Spatial and environmental connectivity analysis in a cholera vaccine trial.

Authors:  Michael Emch; Mohammad Ali; Elisabeth D Root; Mohammad Yunus
Journal:  Soc Sci Med       Date:  2009-01-08       Impact factor: 4.634

7.  Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.

Authors:  Jill M Ferdinands; Manjusha Gaglani; Emily T Martin; Arnold S Monto; Donald Middleton; Fernanda Silveira; H Keipp Talbot; Richard Zimmerman; Manish Patel
Journal:  Clin Infect Dis       Date:  2021-08-16       Impact factor: 9.079

8.  Assessing vaccine durability in randomized trials following placebo crossover.

Authors:  Jonathan Fintzi; Dean Follmann
Journal:  Stat Med       Date:  2021-04-29       Impact factor: 2.497

9.  One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome.

Authors:  I Byren; P Bejon; B L Atkins; B Angus; S Masters; P McLardy-Smith; R Gundle; A Berendt
Journal:  J Antimicrob Chemother       Date:  2009-03-31       Impact factor: 5.790

10.  Controlling endemic cholera with oral vaccines.

Authors:  Ira M Longini; Azhar Nizam; Mohammad Ali; Mohammad Yunus; Neeta Shenvi; John D Clemens
Journal:  PLoS Med       Date:  2007-11-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.